12th IMPACCT RWE Summit 2024

Temas de la conferencia
Digitalization and centralization of datasets have vastly increased the volume of RWD. Advances in AI, deep learning, and large language models have revolutionized big data analysis. Payers and regulators are prioritizing RWE in submissions. These three revolutions are driving a boom in RWE. However, questions remain for clinical, regulatory, and HEOR experts on how to best leverage and disseminate this data.

Observaciones
URL:
Brochure: https://go.evvnt.com/2495675-2?pid=4832

Speakers: Amit Raval, Director - Real-World Evidence Oncology, Bayer, Andrew Goldberg, Chief Operating Officer, HealthVerity, and more

https://go.evvnt.com/2495675-3?pid=4832

Ms. Lauren Thursby